• Axio featured in the list of ’75 startups you can bet on’ published by DARE magazine in its June 2010 edition.
“http://www.dare.co.in/people/75-startups-you-can-bet-on/axio-biosolutions.htm“

• GVFL Ltd. (formerly Gujarat Venture Finance Limited) a leading venture capital firm in India, invested in Axio from Gujarat Venture Biotech Fund.

• Axio got into tie-up with Aegis Lifesciences, a leader in absorbable haemostatic dressings as manufacturing partner for Axiostat.

• Leo Mavely, Managing Director of Axio was invited to deliver a talk at Indian Science Congress’2010 on Therapeutic potential of novel natural biomaterials in preventive and regenerative wound care.

• Pre-clinical animal efficacy studies completed successfully at Sree Chitra Institute of Biomedical sciences, Trivandrum.

• Foundation for MSME Clusters selected Axio for Funding Grant, as part of ‘Developing innovative medical device clusters’

• Pre-clinical safety studies completed successfully at Sree Chitra Institute of Biomedical sciences, Trivandrum.

• Axio Biosolutions Private Limited established

• Incubation of Project-1006 completed successfully after showing promising results in proof-of-concept studies.

• Seedfund upto Rs. 20,00,000 for product development approved by NirmaLabs

• Proposal submitted by Mr. Sheshgiri Bekal & Leo Mavely as Project 1006 got selected for incubation at NirmaLabs, technology business incubator based in Ahmedabad supported by Department of Science and Technology, Government of India